{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:36:44Z","timestamp":1793284604886,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K19329"],"award-info":[{"award-number":["17K19329"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25242046"],"award-info":[{"award-number":["25242046"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijbiomac.2026.154313","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:19:15Z","timestamp":1788275955000},"page":"154313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Development of a drug delivery vehicle protein exhibiting high binding affinity and low leakage of the anti-cancer drug SN-38"],"prefix":"10.1016","volume":"381","author":[{"given":"Masatoshi","family":"Nakatsuji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Muroya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Okubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Teraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihoro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Nishide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruna","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousuke","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Kida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigenori","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Inui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154313_bb0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","article-title":"Targeting drugs to tumours using cell membrane-coated nanoparticles","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.154313_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41392-017-0004-3","article-title":"Controlled drug delivery vehicles for cancer treatment and their performance","volume":"3","author":"Senapati","year":"2018","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2026.154313_bb0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jconrel.2023.03.031","article-title":"Programmed-response cross-linked nanocarrier for multidrug-resistant ovarian cancer treatment","volume":"357","author":"Qu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.154313_bb0020","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.actbio.2023.05.040","article-title":"pH-sensitive tumor-tropism hybrid membrane-coated nanoparticles for reprogramming the tumor microenvironment and boosting the antitumor immunity","volume":"166","author":"Zhang","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijbiomac.2026.154313_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106688","article-title":"Recent advances and clinical translation of liposomal delivery systems in cancer therapy","volume":"193","author":"Chen","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.154313_bb0030","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215308120","article-title":"Dendrimer nanosystems for adaptive tumor-assisted drug delivery via extracellular vesicle hijacking","volume":"120","author":"Jiang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154313_bb0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12943-023-01865-0","article-title":"Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol. Cancer"},{"issue":"45","key":"10.1016\/j.ijbiomac.2026.154313_bb0040","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc1725","article-title":"Trisulfide bond-mediated doxorubicin dimeric prodrug nanoassemblies with high drug loading, high self-assembly stability, and high tumor selectivity","volume":"6","author":"Yang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2026.154313_bb0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejpb.2016.08.018","article-title":"Leakage-free DOX\/PEGylated chitosan micelles fabricated via facile one-step assembly for tumor intracellular pH-triggered release","volume":"108","author":"Zhao","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2026.154313_bb0050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijpharm.2018.09.047","article-title":"A study on the role of cholesterol and phosphatidylcholine in various features of liposomal doxorubicin: from liposomal preparation to therapy","volume":"551","author":"Farzaneh","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154313_bb0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jconrel.2011.12.020","article-title":"Drug delivery system for poorly water-soluble compounds using lipocalin-type prostaglandin D synthase","volume":"159","author":"Fukuhara","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.154313_bb0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejps.2015.04.012","article-title":"Novel oral formulation approach for poorly water-soluble drug using lipocalin-type prostaglandin D synthase","volume":"74","author":"Mizoguchi","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.154313_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142206","article-title":"Human Lipocalin-type prostaglandin D synthase-based drug delivery system for poorly water-soluble anti-Cancer drug SN-38","volume":"10","author":"Nakatsuji","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.154313_bb0070","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1016\/S0022-3549(15)00176-8","article-title":"Development of pH-independent drug release formulation using Lipocalin-type prostaglandin D synthase","volume":"105","author":"Mizoguchi","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.154313_bb0075","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/cmdc.201700454","article-title":"Solubility-improved 10-O-substituted SN-38 derivatives with antitumor activity","volume":"12","author":"Doi","year":"2017","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154313_bb0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jsb.2009.10.005","article-title":"Structural analysis of lipocalin-type prostaglandin D synthase complexed with biliverdin by small-angle X-ray scattering and multi-dimensional NMR","volume":"169","author":"Miyamoto","year":"2010","journal-title":"J. Struct. Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154313_bb0085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1042\/BJ20120324","article-title":"Systematic interaction analysis of human lipocalin-type prostaglandin D synthase with small lipophilic ligands","volume":"446","author":"Kume","year":"2012","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154313_bb0090","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.febslet.2014.02.001","article-title":"Fine-tuned broad binding capability of human lipocalin-type prostaglandin D synthase for various small lipophilic ligands","volume":"588","author":"Kume","year":"2014","journal-title":"FEBS Lett."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.154313_bb0095","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1111\/febs.16791","article-title":"Structural and interaction analysis of human lipocalin-type prostaglandin D synthase with the poorly water-soluble drug NBQX","volume":"290","author":"Miyamoto","year":"2023","journal-title":"FEBS J."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.154313_bb0100","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1021\/acs.molpharmaceut.7b00590","article-title":"Comprehensive evaluation of the binding of Lipocalin-type prostaglandin D synthase to poorly water-soluble drugs","volume":"14","author":"Teraoka","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.154313_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122886","article-title":"Recent advances in SN-38 drug delivery system","volume":"637","author":"Yang","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154313_bb0110","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0090-9556(24)15060-X","article-title":"Pharmacokinetics, metabolism, and excretion of irinotecan (CPT-11) following I.V. infusion of [(14)C]CPT-11 in cancer patients","volume":"28","author":"Slatter","year":"2000","journal-title":"Drug Metab. Dispos."},{"issue":"3\u20134","key":"10.1016\/j.ijbiomac.2026.154313_bb0115","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/sj.bjc.6690364","article-title":"CPT-11 converting carboxylesterase and topoisomerase activities in tumour and normal colon and liver tissues","volume":"80","author":"Guichard","year":"1999","journal-title":"Br. J. Cancer"},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.154313_bb0120","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1200\/JCO.2008.20.6300","article-title":"Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics","volume":"27","author":"Innocenti","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2026.154313_bb0125","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ijpharm.2014.05.046","article-title":"SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb\/c model with breast cancer versus irinotecan","volume":"471","author":"Sepehri","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154313_bb0130","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"Pt 8","key":"10.1016\/j.ijbiomac.2026.154313_bb0135","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1107\/S1399004714012462","article-title":"High-resolution structures of mutants of residues that affect access to the ligand-binding cavity of human lipocalin-type prostaglandin D synthase","volume":"70","author":"Perduca","year":"2014","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.154313_bb0140","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"W1","key":"10.1016\/j.ijbiomac.2026.154313_bb0145","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.154313_bb0150","first-page":"404","article-title":"The \u201cmegaprimer\u201d method of site-directed mutagenesis","volume":"8","author":"Sarkar","year":"1990","journal-title":"Biotechniques"},{"issue":"Pt 2","key":"10.1016\/j.ijbiomac.2026.154313_bb0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","volume":"66","author":"Kabsch, Xds","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154313_bb0160","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1107\/S0021889897006766","article-title":"MOLREP: an automated program for molecular replacement","volume":"30","author":"Vagin","year":"1997","journal-title":"J. Appl. Crystallogr."},{"issue":"Pt 4","key":"10.1016\/j.ijbiomac.2026.154313_bb0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"Pt 4","key":"10.1016\/j.ijbiomac.2026.154313_bb0170","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"Pt 2","key":"10.1016\/j.ijbiomac.2026.154313_bb0175","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"issue":"Pt 4","key":"10.1016\/j.ijbiomac.2026.154313_bb0180","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ijbiomac.2026.154313_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121852","article-title":"On-demand targeting nanotheranostics with stimuli-responsive releasing property to improve delivery efficiency to cancer","volume":"290","author":"Lu","year":"2022","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154313_bb0190","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1194\/jlr.M035410","article-title":"Structural and dynamic insights into substrate binding and catalysis of human lipocalin prostaglandin D synthase","volume":"54","author":"Lim","year":"2013","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154313_bb0195","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1074\/jbc.M209934200","article-title":"Characterization of the unfolding process of lipocalin-type prostaglandin D synthase","volume":"278","author":"Inui","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.154313_bb0200","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/jb\/mvn154","article-title":"Compact packing of lipocalin-type prostaglandin D synthase induced by binding of lipophilic ligands","volume":"145","author":"Inoue","year":"2009","journal-title":"J. Biochem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.154313_bb0205","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1021\/acs.molpharmaceut.6b01109","article-title":"Using affinity to provide Long-term delivery of antiangiogenic drugs in Cancer therapy","volume":"14","author":"Rivera-Delgado","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.154313_bb0210","doi-asserted-by":"crossref","first-page":"8779","DOI":"10.2147\/IJN.S150196","article-title":"Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel","volume":"12","author":"Zhang","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2026.154313_bb0215","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jconrel.2020.10.014","article-title":"Carrier-free nanodrugs for safe and effective cancer treatment","volume":"329","author":"Karaosmanoglu","year":"2021","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154313_bb0220","article-title":"Manipulating calcium homeostasis with nanoplatforms for enhanced cancer therapy","volume":"4","author":"Feng","year":"2024","journal-title":"Exploration (Beijing)"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154313_bb0225","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1039\/D5NH00784D","article-title":"Customized porous aromatic frameworks (PAFs) as an oral antidote for efficient and selective intestinal detoxification","volume":"11","author":"Xi","year":"2026","journal-title":"Nanoscale Horiz."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154313_bb0230","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/d41573-024-00064-w","article-title":"The antibody-drug conjugate landscape","volume":"23","author":"Flynn","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.154313_bb0235","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41573-023-00709-2","article-title":"Antibody-drug conjugates come of age in oncology","volume":"22","author":"Dumontet","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.154313_bb0240","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s40265-020-01337-5","article-title":"Sacituzumab Govitecan: First Approval","volume":"80","author":"Syed","year":"2020","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.154313_bb0245","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-022-00947-7","article-title":"Antibody drug conjugate: the \u201cbiological missile\u201d for targeted cancer therapy","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.154313_bb0250","doi-asserted-by":"crossref","first-page":"18124","DOI":"10.1021\/acs.jmedchem.4c01251","article-title":"Exo-cleavable linkers: enhanced stability and therapeutic efficacy in antibody-drug conjugates","volume":"67","author":"Watanabe","year":"2024","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.154313_bb0255","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.bmcl.2016.02.020","article-title":"Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads","volume":"26","author":"Nakada","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2026.154313_bb0260","article-title":"Structural plasticity in the loop region of engineered lipocalins with novel ligand specificities, so-called Anticalins","volume":"6","author":"Achatz","year":"2022","journal-title":"J. Struct. Biol. X"},{"issue":"6693","key":"10.1016\/j.ijbiomac.2026.154313_bb0265","doi-asserted-by":"crossref","first-page":"eadl2528","DOI":"10.1126\/science.adl2528","article-title":"Generalized biomolecular modeling and design with RoseTTAFold all-atom","volume":"384","author":"Krishna","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2026.154313_bb0270","article-title":"BoltzGen: Toward Universal Binder Design","author":"Stark","year":"2025","journal-title":"bioRxiv"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026042595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026042595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:12:29Z","timestamp":1793283149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026042595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":54,"alternative-id":["S0141813026042595"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154313","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a drug delivery vehicle protein exhibiting high binding affinity and low leakage of the anti-cancer drug SN-38","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"154313"}}